Joel Greenblatt's position in Pfizer is currently worth $22.5M. That's 0.13% of their equity portfolio (171st largest holding). The first Pfizer trade was made in Q1 2011. Since then Joel Greenblatt bought shares 30 more times and sold shares on 26 occasions. The investor's estimated purchase price is $31.2M, resulting in a loss of 28%.